We are live on ! Find out more
MCMC

Matrix Capital Management Company Portfolio holdings

AUM $46.3M
1-Year Est. Return 114.38%
This Fund
S&P 500
This Quarter Est. Return
-6.64%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$8.34B
AUM Growth
-$270M
Cap. Flow
+$392M
Cap. Flow %
4.71%
Top 10 Hldgs %
90.96%
Holding
19
New
–
Increased
4
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$274M
2
ADSK icon
Autodesk
ADSK
+$62M
3
SNPS icon
Synopsys
SNPS
+$48.3M
4
ALTR
Altair Engineering Inc
ALTR
+$8.49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 72.24%
2 Consumer Discretionary 11.19%
3 Industrials 11.07%
4 Healthcare 5.09%
5 Materials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.6T
$1.38B 16.51%
31,637,000
– –
GFS icon
2
GlobalFoundries
GFS
$25.8B
$992M 11.9%
17,048,000
– –
AMAT icon
3
Applied Materials
AMAT
$347B
$976M 11.71%
7,052,700
– –
AMZN icon
4
Amazon
AMZN
$2.44T
$933M 11.19%
7,335,828
– –
TDG icon
5
TransDigm Group
TDG
$70.7B
$923M 11.07%
1,094,900
– –
MRVL icon
6
Marvell Technology
MRVL
$147B
$713M 8.55%
13,166,824
+4,634,127
+54% +$274M
ALTR
7
DELISTED
Altair Engineering Inc
ALTR
$707M 8.48%
11,300,457
+126,257
+1% +$8.49M
WDAY icon
8
Workday
WDAY
$41.5B
$341M 4.09%
1,586,043
– –
SNPS icon
9
Synopsys
SNPS
$71.6B
$329M 3.95%
717,735
+108,000
+18% +$48.3M
ASML icon
10
ASML
ASML
$596B
$293M 3.51%
497,200
– –
ZNTL icon
11
Zentalis Pharmaceuticals
ZNTL
$332M
$280M 3.36%
13,959,973
– –
QCOM icon
12
Qualcomm
QCOM
$164B
$207M 2.48%
1,861,000
– –
ADSK icon
13
Autodesk
ADSK
$51.8B
$85.7M 1.03%
414,000
+295,000
+248% +$62M
ADPT icon
14
Adaptive Biotechnologies
ADPT
$3.61B
$63.1M 0.76%
11,572,590
– –
AURA icon
15
Aura Biosciences
AURA
$725M
$48.1M 0.58%
5,362,870
– –
PRM icon
16
Perimeter Solutions
PRM
$5.66B
$33.9M 0.41%
7,462,500
– –
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
$30.4M 0.36%
38,974,185
– –
VTYX
18
DELISTED
Ventyx Biosciences
VTYX
$3.12M 0.04%
89,900
– –
ZS icon
19
Zscaler
ZS
$24.9B
$2.86M 0.03%
18,405
– –

Similar funds

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Matrix Capital Management Company's Q3 2023 Portfolio in Review

As of Q3 2023, Matrix Capital Management Company held 19 positions worth $8.34B, down 3.1% from $8.61B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Matrix Capital Management Company deployed $392M of net new capital in Q3 2023, adding to 4 existing holdings.

By sector, the portfolio is most concentrated in Technology at 72% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Matrix Capital Management Company added most to Marvell Technology in Q3 2023, an estimated $274M increase.
  • Matrix Capital Management Company's ten largest holdings make up 91% of its $8.34B portfolio in Q3 2023.
  • Matrix Capital Management Company opened 0 new positions and closed 0 in Q3 2023.
  • Matrix Capital Management Company's portfolio value fell 3.1% quarter-over-quarter to $8.34B.

Based on Matrix Capital Management Company's 13F filing for Q3 2023, filed 14 Nov 2023.